Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$188M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$136M |
| 3 |
Danaher
DHR
|
+$133M |
| 4 |
Procter & Gamble
PG
|
+$112M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$101M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.29B |
| 2 |
Microsoft
MSFT
|
+$365M |
| 3 |
Alibaba
BABA
|
+$328M |
| 4 |
Ameren
AEE
|
+$220M |
| 5 |
American Electric Power
AEP
|
+$206M |
Sector Composition
| 1 | Healthcare | 20.2% |
| 2 | Technology | 12.94% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XIFR
1976
XPLR Infrastructure, LP
XIFR
$948M
| $944K | ﹤0.01% |
21,949
-156,107
| -88% | -$6.71M |
|
|
CNR
1977
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $944K | ﹤0.01% |
206,922
+182,228
| +738% | +$831K |
|
|
GSB
1978
DELISTED
GlobalSCAPE, Inc.
GSB
| $944K | ﹤0.01% |
132,592
+120,767
| +1,021% | +$860K |
|
1979
Integer Holdings
ITGR
$3.57B
| $943K | ﹤0.01% |
+14,997
| New | +$943K |
|
1980
RAPT Therapeutics
RAPT
$264M
| $943K | ﹤0.01% |
+5,540
| New | +$943K |
|
1981
UBS Group
UBS
$131B
| $941K | ﹤0.01% |
101,618
-186,658
| -65% | -$1.73M |
|
1982
Mine Safety
MSA
$6.62B
| $940K | ﹤0.01% |
+9,286
| New | +$940K |
|
1983
SuRo Capital
SSSS
$223M
| $938K | ﹤0.01% |
190,769
-73,066
| -28% | -$359K |
|
1984
Prestige Consumer Healthcare
PBH
$3.12B
| $933K | ﹤0.01% |
+25,441
| New | +$933K |
|
|
FRG
1985
DELISTED
Franchise Group, Inc.
FRG
| $933K | ﹤0.01% |
106,962
+51,596
| +93% | +$450K |
|
1986
ImmunityBio
IBRX
$2.55B
| $930K | ﹤0.01% |
322,999
+13,660
| +4% | +$39.3K |
|
1987
Exicure
XCUR
$24.3M
| $920K | ﹤0.01% |
4,146
+3,362
| +429% | +$746K |
|
|
BCLI
1988
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $919K | ﹤0.01% |
+13,203
| New | +$919K |
|
1989
Arq
ARQ
$307M
| $919K | ﹤0.01% |
139,886
-73,361
| -34% | -$482K |
|
1990
British American Tobacco
BTI
$124B
| $916K | ﹤0.01% |
26,784
-114,275
| -81% | -$3.91M |
|
1991
CB Financial Services
CBFV
$167M
| $914K | ﹤0.01% |
+47,321
| New | +$914K |
|
|
IVAC
1992
DELISTED
Intevac Inc
IVAC
| $910K | ﹤0.01% |
222,556
+209,107
| +1,555% | +$855K |
|
|
NYMX
1993
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $909K | ﹤0.01% |
388,656
+44,599
| +13% | +$104K |
|
1994
Stoneridge
SRI
$230M
| $908K | ﹤0.01% |
+54,193
| New | +$908K |
|
|
LITS
1995
Lite Strategy, Inc. Common Stock
LITS
$95.2M
| $907K | ﹤0.01% |
28,166
-6,301
| -18% | -$203K |
|
1996
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $907K | ﹤0.01% |
10,466
-403,426
| -97% | -$35M |
|
|
PPBI
1997
DELISTED
Pacific Premier Bancorp
PPBI
| $903K | ﹤0.01% |
+47,950
| New | +$903K |
|
1998
Dyadic International
DYAI
$35M
| $902K | ﹤0.01% |
173,444
+160,211
| +1,211% | +$833K |
|
1999
AAR Corp
AIR
$2.64B
| $901K | ﹤0.01% |
50,736
+35,147
| +225% | +$624K |
|
|
ECOM
2000
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $901K | ﹤0.01% |
124,139
+83,061
| +202% | +$603K |
|